Ara-C definitions
| Word backwards | C-ara |
|---|---|
| Part of speech | ara-C is a noun. |
| Syllabic division | a-ra-C |
| Plural | The plural form of ara-C is ara-Cs. |
| Total letters | 4 |
| Vogais (1) | a |
| Consonants (2) | r,c |
Ara-C, also known as cytarabine, is a chemotherapy medication used to treat certain types of leukemia. It belongs to a class of drugs called antimetabolites, which interfere with the growth and spread of cancer cells in the body.
Ara-C is commonly used to treat acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow. It can also be used to treat other types of leukemia, lymphoma, and solid tumors.
How does Ara-C work?
When Ara-C is administered, it enters the cancer cells and disrupts their ability to replicate. It works by inhibiting the synthesis of DNA, the genetic material of the cell, ultimately leading to cell death.
Administration of Ara-C
Ara-C is typically given as an injection into a vein (intravenously) or directly into the cerebrospinal fluid for the treatment of certain types of leukemia that have spread to the brain or spinal cord.
Side effects of Ara-C
Common side effects of Ara-C may include nausea, vomiting, diarrhea, mouth sores, decreased appetite, and hair loss. It can also suppress the bone marrow, leading to an increased risk of infections, bleeding, and anemia.
In conclusion, Ara-C is a potent chemotherapy drug used to treat various forms of cancer, particularly leukemia. It works by disrupting the DNA synthesis in cancer cells, ultimately leading to their destruction. While it can be effective in treating cancer, it also comes with a range of side effects that need to be carefully managed by healthcare professionals.
Ara-C Examples
- The chemotherapy drug ara-C is commonly used to treat leukemia.
- Doctors may prescribe ara-C to patients with certain types of cancer.
- Ara-C works by interfering with the growth and spread of cancer cells.
- Some patients may experience side effects from ara-C treatment, such as nausea and fatigue.
- Researchers are studying new ways to enhance the effectiveness of ara-C in cancer therapy.
- Ara-C is also known by its generic name cytarabine.
- Patients undergoing ara-C treatment may require regular blood tests to monitor their response to the drug.
- It is important for healthcare providers to closely monitor patients receiving ara-C for any signs of toxicity.
- Ara-C is typically administered intravenously in a clinical setting under the supervision of medical professionals.
- Patients should follow their healthcare provider's instructions carefully when taking ara-C to maximize its benefits.